Home › Funds › Aisling Capital Management LP › MRKR
Aisling Capital Management LP position in MRKR
MARKER THERAPEUTICS INC · Health Care
Aisling Capital Management LP reported holding 325,370 shares of MRKR (MARKER THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$348K, representing 0.12% of its reported portfolio and ranking #13 among its reported holdings. Aisling Capital Management LP has disclosed MRKR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aisling Capital Management LP's MRKR position evolved
Aisling Capital Management LP first disclosed a stake in MRKR in Q3 2023 at 314,286 shares (US$1.4M). The position peaked in Q4 2023 at 314,286 shares, worth US$1.7M. Across 13 filings, Aisling Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 325,370 shares valued at US$348K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 314.29K | $1.43M | New |
| Q4 2023 | 314.29K | $1.73M | Hold |
| Q1 2024 | 314.29K | $1.35M | Hold |
| Q2 2024 | 314.29K | $1.71M | Hold |
| Q3 2024 | 314.29K | $886.29K | Hold |
| Q4 2024 | 325.37K | $1.01M | Add |
| Q1 2025 | 325.37K | $400.20K | Hold |
| Q2 2025 | 325.37K | $497.82K | Hold |
| Q3 2025 | 325.37K | $290.43K | Hold |
| Q4 2025 | 325.37K | $484.80K | Hold |
| Q1 2026 | 325.37K | $422.98K | Hold |
| Q2 2026 | 325.37K | $478.29K | Hold |
| Q3 2026 | 325.37K | $348.15K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRKR and 13F data
MRKR (MARKER THERAPEUTICS INC) is a Health Care company. 23 other funds we track also report a position in MRKR — the largest reported positions include NEA Management Company, LLC (US$2.4M), Blue Owl Capital Holdings LP (US$593K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRKR
- NEA Management Company, LLC 1.63M sh · $2.39M · Q2 2026
- Blue Owl Capital Holdings LP 554.25K sh · $593.05K · Q3 2026
More on Aisling Capital Management LP
FAQ
How long has Aisling Capital Management LP held MRKR?
Aisling Capital Management LP has disclosed MRKR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Aisling Capital Management LP's current position in MRKR?
As of Q3 2026, Aisling Capital Management LP holds 325.37K shares of MRKR (MARKER THERAPEUTICS INC), valued at $348.15K, representing 0.12% of its reported portfolio and ranking #13.
Has Aisling Capital Management LP been buying or selling MRKR?
In the latest 13F filing (Q3 2026), Aisling Capital Management LP held unchanged its position in MRKR. The position peaked in Q4 2023 at 314.29K shares.
Which other funds hold MRKR?
Other major institutional holders of MRKR include NEA Management Company, LLC, Blue Owl Capital Holdings LP, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.